News Chart Hanall Biopharma Co., Ltd.

Equities

A009420

KR7009420001

End-of-day quote Korea S.E. Other stock markets 03:30:00 07/06/2024 am IST			5-day change	1st Jan Change
34,150 ^KRW	+3.96%		+8.24%	-22.91%

14/05	Hanall Biopharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03/05	HanAll Biopharma Announces Initiation of Phase III Randomized, Double-Masked Vehicle Controlled VELOS-4 Trial Evaluating Tanfanercept for Treatment of Dry Eye Disease	CI

cc508cdc4d8a87.jaIDJ6xtRV6l8fYEN-Ptcs2lno2HdBPvqIf7ZoBZf1g.28xqEuI6KCzJwMc9YJmfSqXS7urAI3-7-P6RE-FuTyj4mjFi6FosB_abzg~820b2bd5ea6aaef59cfcb0bb95ef767f